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Abstract We previously reported the isolation of the cartilage-
derived growth promoting factors chondromodulin-I (ChM-I) 
and chondromodulin-II (ChM-II) from fetal bovine epiphyseal 
cartilage. Both of these factors stimulate the growth and matrix 
formation of chondrocytes in vitro. In the present study, we found 
that ChM-I and ChM-II stimulated the proliferation of clonal 
mouse osteoblastic MC3T3-E1 cells as well as primary mouse 
osteoblasts in culture. Unlike other known growth factors, these 
factors did not support the proliferation of fibroblasts. Con-
comitantly with growth stimulation of osteoblasts, there was a 
reduction of alkaline phosphatase (ALP) activity in the cells, the 
expression of the differentiated phenotype. These results suggest 
that epiphyseal cartilage may play a functional role in long-
itudinal bone growth by production of these unique growth-
promoting factors. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The longitudinal growth of long bones is supported by the 
growth of epiphyseal growth plate cartilage coupled with ac-
tive bone formation (endochondral bone formation). A com-
plex signaling network of local growth factors underlies the 
active proliferation of osteoblasts. Bone is known to be one of 
the major sources of growth factors such as insulin-like 
growth factor-I, fibroblast growth factor (FGF), transforming 
growth factor-P and bone morphogenetic protein [1-3]. These 
local growth factors exert profound effects on the growth and 
expression of the differentiated phenotype of osteoblasts [4,5] 
as well as chondrocytes [6-8]. Previous studies revealed that 
cartilage also contains these growth factors [9-11], suggesting 
that bone and cartilage interact with each other, exchanging 
growth signals in a paracrine fashion. 
The growth and maturation of chondrocytes in the growth 
plate is believed to provide the physical scaffold for bone cells 
at the osteochondral junction. However, the active prolifera-
tion of osteoblasts at the osteochondral junction cannot be 
accounted for by only the common set of growth factors 
present in bone and cartilage. There is a possibility that car-
tilage may send a paracrine growth signal to the bone forming 
cells. We previously isolated the novel heparin-binding growth 
promoting factors chondromodulin-I (ChM-I) and -II (ChM-
*Corresponding author. Fax: (81) (6) 879-2890. 
II) from fetal bovine epiphyseal cartilage [12,13]. These factors 
stimulated growth and proteoglycan synthesis in rabbit 
growth plate chondrocytes in culture [12,13]. In the present 
study, we tested our hypothesis that ChM-I and ChM-II may 
participate in the growth control of osteoblasts by using 
mouse osteoblastic MC3T3-E1 cells and primary osteoblasts 
in culture. 
2. Materials and methods 
2.1. Materials 
ChM-I and ChM-II were purified from guanidinium chloride ex-
tracts of fetal bovine epiphyseal cartilage (embryos 3-6 months old) 
by acetone precipitation, ultrafiltrations, and successive chromatogra-
phy with a Sephacryl S-200 column, a heparin Toyopearl affinity 
column and a YMC Q reverse-phase column, as previously described 
[12,13]. Human recombinant FGF-2 was obtained from R & D Sys-
tems (Minneapolis, MN). 
2.2. Cell culture 
A clonal mouse osteoblastic cell line, MC3T3-E1, was maintained 
in a-MEM containing 10% fetal bovine serum (FBS) at 37°C under 
5% CO2 in air and subcultured every third day [14]. In each well of a 
48-microwell plate, 1.5 X103 cells were plated with a-MEM contain-
ing 0.3% FBS and various concentrations of ChM-I or ChM-II. After 
incubation for 3 days, the cells were stripped off the plates with tryp-
sin-EDTA solution (Sigma, St. Louis, MO), and their number was 
counted with a hemocytometer. For the determination of DNA syn-
thesis and alkaline phosphatase (ALP) activity, the cells were grown 
to confluency in a-MEM containing 10% FBS. The cells were then 
preincubated in a-MEM containing a low concentration of serum 
(0.3% FBS) for 24 h to allow the cells to become quiescent, and 
then incubated in a-MEM containing test samples in the presence 
of 0.3% FBS for another 24 h ([3H]thymidine incorporation) or 48 
h (ALP activity). For the isolation of primary osteoblasts and fibro-
blasts, calvariae and lungs from 3-day-old ICR mice were cut into 
pieces with scissors and cultured separately in 35-mm dishes with a-
MEM containing 10% FBS. After 5 days, cells migrating from the 
tissue fragments were subcultured. The [3H]thymidine incorporation 
and ALP activity of these cells were measured under the culture con-
ditions described for the MC3T3-E1 cells. 
A clonal mouse chondrogenic cell line, ATDC5, was maintained in 
the medium consisting of a 1:1 mixture of DME and Ham's F-12 
medium containing 5% FBS containing 10 |ig/ml human transferrin 
(Boehringer Mannheim GmbH, Mannheim, Germany) and 3 X 10~8 
M sodium selenite (Sigma, St. Louis, MO) at 37°C under 5% C02 in 
air, as previously described [15]. Chondrogenic differentiation of the 
cells was induced by the above medium supplemented with 10 |xg/ml 
bovine insulin (Wako Pure Chemicals, Osaka, Japan) [15]. 
2.3. [3H]Thymidine incorporation and ALP activity 
The cells treated for 24 h with test samples were labeled for the last 
3 h with [methyl-3H]thymidine (1 uCi/well; NEN, Boston, MA). The 
cells were then scraped into 1 ml of cold phosphate-buffered saline 
(PBS) and precipitated with 10% trichloroacetic acid (final concentra-
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Fig. 1. Effects of ChM-I and ChM-II on [3H]thymidine incorporation in the mouse osteoblastic cell line MC3T3-E1. The cells were treated 
with various concentrations of ChM-I (A) or ChM-II (B) for 24 h, and labeled with [3H]thymidine for the last 3 h of the incubation. Values 
are means ± S.D. of 4 wells. *P < 0.05 versus the control. 
tion). The precipitates were washed with diethylether-ethanol (1:3, v/ 
v). The radioactivity in the acid-insoluble materials was counted in a 
liquid scintillation counter. For the determination of ALP activity, the 
cells treated for 48 h with test samples were scraped into 0.05% Triton 
X-100 and solubilized by three cycles of freezing and thawing. The 
resultant supernatant was used for the assay of ALP activity by the 
method described previously [16], with p-nitrophenyl phosphate used 
as the substrate. Part of the supernatant was used to determine the 
protein content, which was measured by the method of Bradford [17]. 
The data are expressed as means ± S.D. Statistical analysis was carried 
out by one-way analysis of variance, and significance was determined 
by a multiple comparison procedure (Tukey-Kramer test). 
with an appropriate probe (106 cpm/ml) in solutions containing 50% 
formamide, 6XSSPE, as described [15]. Hybridization probes were 
prepared by the random-primer method with a BcaBEST Labeling 
kit (Takara, Otsu, Japan) using the appropriate cDNA fragments: 
1.4 kb EcoRI fragment of pKT1180 [19] as a probe for al(II) collagen 
mRNA; 1.3 kb EcoRI fragment of pCSl harboring mouse ChM-I 
cDNA which was isolated from a mouse 17-day embryo cDNA li-
brary and subcloned into pGEM 3Zf(+) (Promega Corporation, Mad-
ison, WI) (C. Shukunami, submitted for publication). The filters were 
washed twice for 15 min at 55°C in O.lxSSPE and 0.1% SDS, and 
were exposed to Kodak X-OMAT film at —80°C with a Cronex light-
ening plus intensifying screen (DuPont, Boston, MA). 
2.4. RNA extraction and hybridization analysis 
MC3T3-E1 (6X104 cells/well) and ATDC5 cells (6x l0 4 cells/well) 
were inoculated in 6-multiwell plates. For induction of chondrogene-
sis, ATDC5 cells were cultured in the presence of 10 ug/ml insulin for 
21 days. Total RNA was prepared from the cultures by a single-step 
method according to Chomczynski and Sacchi [18]. Total RNA (20 
ug) was denatured with 6% formaldehyde, separated by 1% agarose 
electrophoresis, and transferred on Nytran membranes (Schleicher & 
Schuell, Germany). Hybridization was performed overnight at 42°C 
3. Results and discussion 
In a preliminary study, the medium conditioned by rabbit 
growth plate chondrocytes stimulated [3H]thymidine incorpo-
ration into osteoblastic MC3T3-E1 cells (M. Kumegawa, un-
published data). This implies that growth plate chondrocytes 
produce some humoral factors that stimulate the proliferation 
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Fig. 2. Effects of ChM-I and ChM-II on the number of MC3T3-E1 cells. The cells were treated for 3 days with various concentrations of 
ChM-I (A) or ChM-II (B). Values are means ± S.D. of 4 wells. *P < 0.05 versus the control. 
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Fig. 3. Effects of ChM-I and ChM-II on the alkaline phosphatase (ALP) activity of MC3T3-E1 cells. The cells were treated with varying con-
centrations of ChM-I (A) or ChM-II (B) for 48 h. Values are means ±S.D. of 4 wells. *P<0.05 versus the control. 
of osteoblasts. The discovery of the novel factors ChM-I and 
-II in epiphyseal cartilage suggested to us that these factors 
could be candidates for the cartilage-derived signaling mole-
cules which act on osteoblasts. 
To make the cells quiescent, MC3T3-E1 cells were grown to 
confluency and further preincubated under the low serum 
condition (0.3% FBS). Quiescent confluent cultures of 
MC3T3-E1 cells were then treated with ChM-I or ChM-II 
in the presence of 0.3% FBS for 24 h (Fig. 1). The 
[3H]thymidine incorporation of the cells was stimulated in a 
dose-dependent manner. The stimulatory effects of ChM-I 
and ChM-II were detectable at 300 ng/ml, and DNA synthesis 
of the cells reached a 2-3-fold increase at 1 |xg/ml. In accord-
ance with these findings, ChM-I and ChM-II stimulated the 
proliferation of MC3T3-E1 cells (Fig. 2). The cells were plated 
at the density of 1.5 XlO3 cells/well, and further incubated 
with various concentrations of ChM-I or ChM-II in the pres-
ence of 0.3% FBS. During the 3-day incubation of the sparse 
culture, the cell number increased by 2-4-fold without ChM-I 
or ChM-II in the control cultures, depending on the experi-
ment. In the presence of ChM-I or ChM-II, the cell number 
increased in a dose-dependent manner, and became 2-3-fold 
greater than that of the control at the concentration of 300 
ng/ml. 
As shown in Fig. 3, we studied the effect of these ChM-I 
and ChM-II on the expression of the differentiated phenotype 
of osteoblasts, i.e. the ALP activity in MC3T3-E1 cells. The 
ALP activity was reduced with increasing doses of ChM-I or 
ChM-II. The effect was evident at the concentration of 100-
300 ng/ml, at which dose ChM-I and ChM-II stimulated 
DNA synthesis of the cells. The expression of the differenti-
ated phenotype is reciprocally correlated with the growth rate 
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Fig. 4. Effects of ChM-I and ChM-II on [3H]thymidine incorporation into primary calvarial osteoblasts and pulmonary fibroblasts, and on the 
ALP activity of the calvarial osteoblasts. For the assay of [3H]thymidine (A) and ALP activity (B), the cells were cultured for 24 h and 48 h, 
respectively, with or without ChM-I or ChM-II at 300 ng/ml. The [3FTJthymidine incorporations in control wells of the osteoblasts and the fi-
broblasts were 1687 ± 214 dpm/well and 814 ± 163 dpm/well, respectively. The ALP activity in the control wells of the osteoblasts was 75.517.8 
nmol/mg protein/min. Values are means ± S.D. for 4 wells. *P < 0.05 versus the control. 
Y. Mori et allFEBS Letters 406 (1997) 310-314 313 
Fig. 5. Northern blot analysis of ChM-I and type II collagen 
mRNAs in MC3T3-E1 cells and chondrogenic ATDC5 cells. Cells 
were grown in 6-multiwell plates. Total RNA was isolated from 
MC3T3-E1 cells on day 10, from the undifferentiated ATDC5 cells 
on day 3, or from the differentiated ATDC5 cells on day 21 of cul-
ture. RNA (20 ug) was loaded in each lane and then hybridized 
with mouse ChM-I cDNA or rat type II collagen cDNA. The posi-
tions of 28S and 18S ribosomal RNAs are indicated. The lowest 
panel shows ethidium bromide-stained gel. 
of MC3T3-E1 cells [16], as generally observed in other cell 
types [20]. Thus, the treatments of the cells with ChM-I or 
ChM-II resulted in a shift of cellular status from the maturing 
to the actively growing status. 
The primary osteoblasts isolated from mouse calvariae 
showed a more mature phenotype than those of the clonal 
MC3T3-E1 cells, as characterized by the higher ALP activity 
and the lower growth rate. Fig. 4 illustrates that the above 
observations gained from MC3T3-E1 cell cultures can be ex-
tended to the authentic primary osteoblasts: stimulation of 
DNA synthesis and reduction of the ALP activity of osteo-
blasts by ChM-I and by ChM-II. 
Among the known growth factors, FGF is known as the 
most potent growth stimulator of osteoblasts as well as chon-
drocytes [5]. As shown in Table 1, FGF-2 stimulated the 
[3H]thymidine incorporation of MC3T3-E1 cells to a much 
higher level than did ChM-I or ChM-II. However, FGF stim-
ulates the proliferation of the cells of mesenchymal origin, 
irrespective of cell type. Intriguingly, ChM-I and ChM-II 
stimulated the DNA synthesis of osteoblasts, whereas they 
exerted no growth stimulation in mouse lung fibroblasts 
(Fig. 4A). ChM-I and ChM-II additively stimulated DNA 
synthesis of the osteoblastic cells even in the presence of 
FGF-2 (Table 1). The additive nature and specificity of action 
suggest that ChM-I and ChM-II bring to osteoblasts and 
chondrocytes a growth advantage over the surrounding mes-
enchymal cells under the conditions that FGF is commonly 
available for the cells. Compared to FGF, ChM-I and ChM-II 
require a much higher dose to stimulate osteoblasts and chon-
drocytes (Figs. 1 and 2). However, an abundance of these 
factors in cartilage may compensate for the higher dose re-
quirement for action in osteoblasts at the osteochondral junc-
tion [12,13]. 
Fibroblast growth factor exhibits pleiotropic effects depend-
ing on the target tissue. Cartilage and bone are the major 
source of FGF [21], although factors of the FGF family are 
also widely distributed in the body [22]. In contrast, expres-
sion of ChM-I mRNA was specific to cartilage. No transcript 
for the ChM-I gene was detected in the bony tissue by the in 
situ hybridization technique (Y. Hiraki, unpublished data). As 
shown in Fig. 5, there was no ChM-I mRNA detected in 
osteoblasts such as MC3T3-E1 cells by Northern blot analy-
sis. However, the transcript was evidently expressed in the 
differentiated ATDC5 cells which expressed cartilage pheno-
type such as expression of the type II collagen gene [15], while 
no ChM-I mRNA was detected in the undifferentiated 
ATDC5 cells (Fig. 5). The tissue-specific distribution of 
ChM-II transcripts is not clear at this moment because mo-
lecular cloning of ChM-II is still uncompleted. However, it 
has been shown that there is an abundant expression of 
ChM-II protein in cartilage [13]. These results substantiate a 
possibility that these proteins may function as the paracrine 
growth promoting factors. 
The present findings suggest that epiphyseal growth plate 
cartilage may be functionally involved in the active prolifer-
ation of osteoblasts at the osteochondral junction, and hence 
in the longitudinal growth of long bones by sending a specific 
Table 1 
DNA synthesis of MC3T3-E1 cells stimulated by ChM-I or ChM-II in the presence or absence of FGF-2 
[3H]Thymidine incorporation (% of control) 
None ChM-I 
None 100.0 ±11.4 146.9 ±16.8 
FGF-2 (0.2 ng/ml) 295.9±31.6 366.2±42.4 
ChM-II 
140.5 ±14.7 
342.9 ±51.4 
ChM-I and ChM-II were used at 300 ng/ml. [3H]Thymidine incorporation of cultures without any agents (control) was (1.34±0.15)X 104 dpm/well. 
Data are presented as the mean ± S.D. (n=5). 
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growth-stimulating signal. The cell-surface receptors for 
ChM-I and ChM-II and the mechanism of their signal trans-
duction remain to be elucidated. 
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